Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06114849 · ClinicalTrials.gov registry record · NA

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)

A NA study, sponsored by Harvard University.

Terminated
Registry status
NA
Development phase
29
Enrollment target

NCT06114849: Clinical Trial NA study, sponsored by Harvard University.

NCT06114849 is a NA study that was terminated before completion, run by Harvard University. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06114849, a NA study, was terminated before completion, sponsored by Harvard University.

TERMINATED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

This clinical trial is part of a series of brief interventions to reduce suicide risk in collaboration with the social media platform RallyPoint, a site specifically designed for U.S. servicemembers and veterans to connect with one another. In this RCT (Intervention 3: Professional Outreach), the investigators will test a psychoeducational intervention aimed at increasing users' likelihood of reaching out to mental health resources (e.g., suicide hotline) when experiencing distress.

Primary Outcome

The investigators are primarily interested in whether participants in both groups contacted professional/emergency services after receiving the intervention or treatment-as-usual. Participants will be sent follow-up surveys to ask about which resources they have contacted.

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Barrier Reduction Intervention

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2023-11-20
Est. Completion 2025-03-14
Phase NA
Harvard University

37 total trials

Why NCT06114849 stopped before completion

NCT06114849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.

NCT06114849 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06114849 about?

NCT06114849 is a clinical study titled "Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)". This clinical trial is part of a series of brief interventions to reduce suicide risk in collaboration with the social media platform RallyPoint, a site specifically designed for U.S. servicemembers and veterans to connect with one another. In this RCT (Intervention 3: Professional Outreach), the in...

What is the current status of trial NCT06114849?

This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2023-11-20. Estimated completion is 2025-03-14.

What interventions are being tested in trial NCT06114849?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Barrier Reduction Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06114849?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06114849's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06114849, the US trial registry maintained by the National Library of Medicine. NCT06114849 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.